Oral Abstract: TCL-150: The ECHELON-2 Trial: 5-Year Results of a Randomized, Double-Blind, Phase 3 Study of Brentuximab Vedotin and CHP (A+CHP) Versus CHOP in Frontline Treatment of Patients with CD30-Positive Peripheral T-Cell Lymphoma
Year: 2021
Type: article
Authors: Swaminathan Iyer, Lorenz Trümper, Owen A. O’Connor, Barbara Pro, Tim Illidge, Ranjana Advani, Nancy L. Bartlett, Jacob Haaber Christensen, Franck Morschhauser, Eva Domingo-Domenech, Giuseppe Rossi, Won Seog Kim, Tatyana Feldman, Tobias Menne, David Belada, Árpád Illès, Kensei Tobinai, Kunihiro Tsukasaki, Su-Peng Yeh, Andrei Shustov, Andreas Hüttmann, Kerry J. Savage, Sam Yuen, Pier Luigi Zinzani, Harry Miao, Veronica Bunn, Keenan Fenton, Michelle Fanale, Markus Puhlmann, Steven Horwitz
Institutions: The University of Texas MD Anderson Cancer Center, Universitätsmedizin Göttingen, TG Therapeutics, Inc. (United States), University of Virginia, Northwestern University, Manchester Academic Health Science Centre, University of Manchester, The Christie Hospital, The Christie NHS Foundation Trust, NIHR Manchester Biomedical Research Centre, Stanford University, Washington University in St. Louis, Odense University Hospital, Centre Hospitalier Universitaire de Lille, Institut Català d'Oncologia, Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia, Samsung Medical Center, Hackensack University Medical Center, Freeman Hospital, Charles University, University Hospital Hradec Králové, University of Debrecen, National Cancer Center Hospital, Saitama International Medical Center, Saitama Medical University, China Medical University Hospital, University of Washington Medical Center, Essen University Hospital, BC Cancer Agency, University of British Columbia, Calvary Mater Newcastle Hospital, University of Bologna, Takeda Oncology (United States), Seagen (United States), Memorial Sloan Kettering Cancer Center
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W3198263140